Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Sales | 1,349,130 | 1,273,721 | 1,299,744 | 1,253,793 | 1,281,256 |
| Cost of Goods | 160,132 | 140,496 | 152,566 | 141,360 | 130,025 |
| Gross Profit | 1,188,998 | 1,133,225 | 1,147,178 | 1,112,433 | 1,151,231 |
| Operating Expenses | 924,171 | 875,395 | 931,991 | 906,188 | 806,866 |
| Operating Income | 264,959 | 258,326 | 215,753 | 206,605 | 344,390 |
| Other Income | 38,526 | 54,153 | 34,300 | 8,674 | 10,122 |
| Pre-tax Income | 303,485 | 312,479 | 250,053 | 215,279 | 354,512 |
| Income Tax | 46,993 | 48,163 | 48,409 | 31,381 | 36,689 |
| Net Income Continuous | 256,492 | 264,316 | 201,644 | 183,898 | 317,823 |
| Minority Interests | 1,474 | 2,491 | 988 | -189 | 7,596 |
| Net Income | $255,018 | $261,825 | $200,656 | $184,087 | $310,227 |
| EPS Basic Total Ops | 2.66 | 2.74 | 2.10 | 1.84 | 3.07 |
| EPS Basic Continuous Ops | 2.68 | 2.77 | 2.11 | 1.84 | 3.14 |
| EPS Diluted Total Ops | 2.62 | 2.69 | 2.05 | 1.81 | 2.97 |
| EPS Diluted Continuous Ops | 2.63 | 2.72 | 2.06 | 1.80 | 3.04 |
| EPS Diluted Before Non-Recurring Items | 3.17 | 2.82 | 2.60 | 2.24 | 3.06 |
| EBITDA(a) | $363,556 | $342,734 | $310,407 | $311,654 | $458,520 |